Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus

被引:71
作者
Corona, G
Mannucci, E
Mansani, R
Petrone, L
Bartolini, M
Giommi, R
Forti, G
Maggi, M
机构
[1] Univ Florence, Dept Clin Physiopathol, Androl Unit, I-50139 Florence, Italy
[2] Univ Florence, Dept Clin Physiopathol, Endocrinol Unit, Florence, Italy
[3] Univ Florence, Dept Clin Physiopathol, Radiol Unit, Florence, Italy
[4] Int Inst Sexuol, Florence, Italy
关键词
diabetes mellitus; testosterone; erectile dysfunction; PDE5; SIEDY (c);
D O I
10.1016/j.eururo.2004.03.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Diabetes mellitus-induced erectile dysfunction (DMED) is thought to be multifactorial in aetiology and to include vascular, neurological, and psychological components. The aim of the present study is to determine the contribution of organic, relational, and intrapsychic components to the pathogenesis of ED in diabetic in comparison with non-diabetic patients. Methods: We studied a consecutive series of 1027 using SIEDY(C) structured interview. A complete physical examination and a series of metabolic, biochemical, hormonal, psychometric, penile vascular tests and nocturnal penile tumescence and rigidity evaluations were performed. Results: 15% of patient studied were affected by DMED. Diabetic patients with DMED have a greater severity of erectile dysfunction and are more likely to have an organic, rather than an intrapsychic, component. Impaired sexual desire is less frequent in these patients and they had an higher prevalence of hypogonadism than non-diabetic individuals. Conclusion: Diabetic patients seeking treatment for erectile dysfunction have a greater severity of disease, less impaired sexual desire, suggesting that the need for medical care in diabetic patients with ED could be even greater than in their non-diabetic counterparts. Considering the higher prevalence of obesity-related decrease of testosterone levels in DMED, an appropriate screening and treatment of hypogonadism might improve the outcome of pharmacotherapy for ED in diabetic patients. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:222 / 228
页数:7
相关论文
共 35 条
  • [1] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [2] 2-S
  • [3] Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction
    Aversa, A
    Isidori, AM
    Spera, G
    Lenzi, A
    Fabbri, A
    [J]. CLINICAL ENDOCRINOLOGY, 2003, 58 (05) : 632 - 638
  • [4] Hypogonadism and diabetes
    Betancourt-Albrecht, M
    Cunningham, GR
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2003, 15 (Suppl 4) : S14 - S20
  • [5] The neuropathy of erectile dysfunction
    Bleustein, CB
    Arezzo, JC
    Eckholdt, H
    Melman, A
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (06) : 433 - 439
  • [6] BRODERICK GA, 1999, TXB ERECTILE DYSFUNC, P149
  • [7] Expression of functional leptin receptors in rodent Leydig cells
    Caprio, M
    Isidori, AM
    Carta, AR
    Moretti, C
    Dufau, ML
    Fabbri, A
    [J]. ENDOCRINOLOGY, 1999, 140 (11) : 4939 - 4947
  • [8] CORONA G, 2004, IN PRESS INT J IMPOT
  • [9] Optimizing treatment for diabetes mellitus induced erectile dysfunction
    Costabile, RA
    [J]. JOURNAL OF UROLOGY, 2003, 170 (02) : S35 - S38
  • [10] Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men:: The HERITAGE family study
    Couillard, C
    Gagnon, J
    Bergeron, J
    Leon, AS
    Rao, DC
    Skinner, JS
    Wilmore, JH
    Després, JP
    Bouchard, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) : 1026 - 1031